CONFIDENTIAL — APPROVED FOR PUBLIC RELEASE · BUREAU FILE COPY RECORDS CURRENT AS OF 29 MAY 2026 · DISTRIBUTION: UNRESTRICTED
VendorInvestigate Independent Testing Bureau · Public Records Division
DOCKET YEAR 2026 · VOL. II
13,421 SAMPLES ON FILE
No fee · No favor
Compound Evidence File
#EC-2026-0770

4-Piperidone CAS 41661-47-6

Filed under Raw Materials. The bureau holds 53 laboratory returns for this compound from 18 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.

Cross-Index

Subjects Shipping This Compound

18 SUBJECTS
SubjectGradeSamplesMeanMinMaxFirst seenLast seen
Tianjin Finder Chemical TFCCASE #VI-2026-0693A510.09.910.014 Nov 202516 Apr 2026
Shanghai JinBei Chemical TechnologyCASE #VI-2026-0107X110.010.010.09 Jun 20259 Jun 2025
Paradigm PeptideCASE #VI-2026-0759X110.010.010.013 Feb 202513 Feb 2025
HomopeptideCASE #VI-2026-0760A49.99.910.023 May 202623 May 2026
Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594A69.26.910.024 May 202624 May 2026
Qingdao Sigma Chemical QSCCASE #VI-2026-0538A59.17.39.924 May 202624 May 2026
Glbiochem (Shanghai)CASE #VI-2026-0704A39.08.110.024 May 202624 May 2026
Nantong Guangyuan Chemical GYCCASE #VI-2026-0284A88.57.110.024 May 202624 May 2026
Shanghai Sigma Audley SSACASE #VI-2026-0486A48.47.49.324 May 202624 May 2026
Peptide CraftersCASE #VI-2026-0994X27.66.98.320 Jun 202524 May 2026
Reta-PeptideCASE #VI-2026-0756X97.46.08.720 Jun 202517 May 2026
M-PeptidesCASE #VI-2026-0442X17.47.47.421 May 202521 May 2025
PeptiAtlasCASE #VI-2026-0739X17.27.27.22 Apr 20252 Apr 2025
Xingtai Pukelai Technology CoCASE #VI-2026-0850X17.27.27.27 May 20257 May 2025
Haikou Mingheng BiotechnologyCASE #VI-2026-0126X16.96.96.911 Jun 202511 Jun 2025
Richards Biotech Simply RichardsCASE #VI-2026-0307X16.56.56.524 Apr 202524 Apr 2025
Coffee and PeppersCASE #VI-2026-0274X11.11.11.124 Apr 202524 Apr 2025
HK Fat CatCASE #VI-2026-0376X10.00.00.027 Feb 202527 Feb 2025

Open any subject to view the batch-level evidence for 4-Piperidone CAS 41661-47-6 alone.